On the public citation graph
Immunotherapy for lung cancer
0 signed · 424 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ijc.20271openalex-snapshot
Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy
inferredcites →https://doi.org/10.1007/s00262-014-1547-6openalex-snapshot
Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy
inferredcites →https://doi.org/10.1007/s12032-010-9515-2openalex-snapshot
High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
inferredcites →https://doi.org/10.1016/j.cell.2011.02.013openalex-snapshot
Hallmarks of Cancer: The Next Generation
inferredcites →https://doi.org/10.1016/j.ctrv.2015.11.001openalex-snapshot
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy
inferredcites →https://doi.org/10.1016/j.ejca.2014.11.002openalex-snapshot
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours
inferredcites →https://doi.org/10.1016/j.molimm.2011.09.014openalex-snapshot
PD-L2 is predominantly expressed by Th2 cells
inferredcites →https://doi.org/10.1016/j.pharmthera.2015.05.004openalex-snapshot
Vaccine immunotherapy in lung cancer: Clinical experience and future directions
inferredcites →https://doi.org/10.1016/j.smim.2015.11.003openalex-snapshot
Reprogramming the tumor microenvironment to enhance adoptive cellular therapy
inferredcites →https://doi.org/10.1016/j.vaccine.2010.08.002openalex-snapshot
TLR-based immune adjuvants
inferredcites →https://doi.org/10.1016/s0140-6736(89)91609-7openalex-snapshot
TUMOUR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN TREATMENT OF ADVANCED CANCER
inferredcites →https://doi.org/10.1016/s1470-2045(15)00483-0openalex-snapshot
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial
inferredcites →https://doi.org/10.1016/s2213-2600(13)70159-0openalex-snapshot
Lung cancer: potential targets for immunotherapy
inferredcites →https://doi.org/10.1016/s2213-2600(15)00092-2openalex-snapshot
Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study
inferredcites →https://doi.org/10.1021/bi0155899openalex-snapshot
Molecular Cloning and Functional Expression of a Human Intestinal Lactoferrin Receptor
inferredcites →https://doi.org/10.1038/70932openalex-snapshot
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
inferredcites →https://doi.org/10.1038/85330openalex-snapshot
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
inferredcites →https://doi.org/10.1038/nature10755openalex-snapshot
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
inferredcites →https://doi.org/10.1038/nature12477openalex-snapshot
Signatures of mutational processes in human cancer
inferredcites →https://doi.org/10.1038/nature13385openalex-snapshot
Comprehensive molecular profiling of lung adenocarcinoma
inferredcites →https://doi.org/10.1038/nature14011openalex-snapshot
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
inferredcites →https://doi.org/10.1056/nejmoa1200690openalex-snapshot
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
inferredcites →https://doi.org/10.1056/nejmoa1311107openalex-snapshot
Ceritinib in ALK -Rearranged Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1408440openalex-snapshot
First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1501824openalex-snapshot
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1504030openalex-snapshot
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1504627openalex-snapshot
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1507643openalex-snapshot
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1073/pnas.1533209100openalex-snapshot
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
inferredcites →https://doi.org/10.1080/2162402x.2015.1005501openalex-snapshot
Restoration of defective cross-presentation in tumors by gemcitabine
inferredcites →https://doi.org/10.1080/2162402x.2015.1042201openalex-snapshot
TLR activation and ionizing radiation induce strong immune responses against multiple tumor entities
inferredcites →https://doi.org/10.1084/jem.190.3.355openalex-snapshot
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
inferredcites →https://doi.org/10.1084/jem.192.7.1027openalex-snapshot
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
inferredcites →https://doi.org/10.1084/jem.193.7.839openalex-snapshot
B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells
inferredcites →https://doi.org/10.1093/annonc/mdr030openalex-snapshot
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
inferredcites →https://doi.org/10.1093/annonc/mdt371openalex-snapshot
Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)
inferredcites →https://doi.org/10.1093/annonc/mdu347.1openalex-snapshot
Magrit, a Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of the Recmage-A3 + As15 Cancer Immunotherapeutic As Adjuvant Therapy in Patients with Resected Mage-A3-Positive Non-Small Cell Lung Cancer (Nsclc)
inferredcites →https://doi.org/10.1093/annonc/mdv323openalex-snapshot
Why has active immunotherapy not worked in lung cancer?
inferredcites →https://doi.org/10.1093/jnci/djt072openalex-snapshot
Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
inferredcites →https://doi.org/10.1097/jto.0b013e31812f3c1aopenalex-snapshot
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours
inferredcites →https://doi.org/10.1126/science.aaa1348openalex-snapshot
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
inferredcites →https://doi.org/10.1126/science.aad0095openalex-snapshot
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
inferredcites →https://doi.org/10.1126/scitranslmed.3003689openalex-snapshot
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
inferredcites →https://doi.org/10.1155/2012/656340openalex-snapshot
Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
inferredcites →https://doi.org/10.1158/0008-5472.can-06-4080openalex-snapshot
Requirement for IFN-γ, CD8+ T Lymphocytes, and NKT Cells in Talactoferrin-Induced Inhibition of neu+ Tumors
inferredcites →https://doi.org/10.1158/0008-5472.can-11-3722openalex-snapshot
Exploiting the Mutanome for Tumor Vaccination
inferredcites →https://doi.org/10.1158/0008-5472.can-13-2698openalex-snapshot
TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-06-0098openalex-snapshot
Genomic Approaches to Lung Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-06-2008openalex-snapshot
Oral Lactoferrin Results in T Cell–Dependent Tumor Inhibition of Head and Neck Squamous Cell Carcinoma In vivo
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-1624openalex-snapshot
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
inferredcites →https://doi.org/10.1158/2326-6066.cir-13-0078openalex-snapshot
Immune Checkpoint Inhibitors: Making Immunotherapy a Reality for the Treatment of Lung Cancer
inferredcites →https://doi.org/10.1158/2326-6066.cir-13-0143openalex-snapshot
TLR7 Ligand Augments GM-CSF–Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic Cells
inferredcites →https://doi.org/10.1159/000075220openalex-snapshot
Lactoferrin Inhibits Growth of Malignant Tumors of the Head and Neck
inferredcites →https://doi.org/10.1172/jci36551openalex-snapshot
Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
inferredcites →https://doi.org/10.1177/1758834014567470openalex-snapshot
Nivolumab in NSCLC: latest evidence and clinical potential
inferredcites →https://doi.org/10.1186/1471-2407-14-969openalex-snapshot
The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40
inferredcites →https://doi.org/10.1186/2051-1426-2-s3-p179openalex-snapshot
Development of MEDI4736, an anti-programmed cell death ligand 1 (PD-L1) antibody, as monotherapy or in combination with other therapies in the treatment of non-small cell lung cancer (NSCLC)
inferredcites →https://doi.org/10.1200/jco.2005.01.109openalex-snapshot
Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206
inferredcites →https://doi.org/10.1200/jco.2008.17.8954openalex-snapshot
Anti–Cytotoxic T-Lymphocyte Antigen-4 Antibody: The First in an Emerging Class of Immunomodulatory Antibodies for Cancer Treatment
inferredcites →https://doi.org/10.1200/jco.2010.32.8971openalex-snapshot
Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1200/jco.2011.38.4032openalex-snapshot
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
inferredcites →https://doi.org/10.1200/jco.2012.45.8703openalex-snapshot
Harnessing the Immune System for the Treatment of Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1200/jco.2013.51.4802openalex-snapshot
Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma
inferredcites →https://doi.org/10.1200/jco.2014.32.15_suppl.8023openalex-snapshot
Nivolumab (anti-PD-1; BMS-936558, ONO-4538) and ipilimumab in first-line NSCLC: Interim phase I results.
inferredcites →https://doi.org/10.1200/jco.2014.32.15_suppl.8056openalex-snapshot
An international, multicenter, randomized, double-blind phase III study of maintenance belagenpumatucel-l in non-small cell lung cancer (NSCLC): Updated analysis of patients enrolled within 12 weeks of completion of chemotherapy.
inferredcites →https://doi.org/10.1200/jco.2014.32.15_suppl.8112openalex-snapshot
Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients (pts) with advanced non-small-cell lung cancer (NSCLC): Survival and clinical activity by subgroup analysis.
inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.3014openalex-snapshot
Phase Ib study of MEDI4736, a programmed cell death ligand-1 (PD-L1) antibody, in combination with tremelimumab, a cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) antibody, in patients (pts) with advanced NSCLC.
inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.3042openalex-snapshot
Tremelimumab, a fully human anti-CTLA-4 monoclonal antibody, optimal dosing regimen for patients with unresectable malignant mesothelioma (MM).
inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.3044openalex-snapshot
Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic or locally advanced solid tumors: assessment of safety and tolerability in a phase I, open-label expansion study.
inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.8010openalex-snapshot
Efficacy, safety and predictive biomarker results from a randomized phase II study comparing MPDL3280A vs docetaxel in 2L/3L NSCLC (POPLAR).
inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.8011openalex-snapshot
Phase 1 study of pembrolizumab (pembro; MK-3475) plus ipilimumab (IPI) as second-line therapy for advanced non-small cell lung cancer (NSCLC): KEYNOTE-021 cohort D.
inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.8025openalex-snapshot
First-line monotherapy with nivolumab (NIVO; anti-programmed death-1 [PD-1]) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy and correlation of outcomes with PD-1 ligand (PD-L1) expression.
inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.8028openalex-snapshot
Clinical activity and safety from a phase II study (FIR) of MPDL3280A (anti-PDL1) in PD-L1–selected patients with non-small cell lung cancer (NSCLC).
inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.8029openalex-snapshot
Clinical activity, safety and predictive biomarkers of the engineered antibody MPDL3280A (anti-PDL1) in non-small cell lung cancer (NSCLC): update from a phase Ia study.
inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.8031openalex-snapshot
Pembrolizumab (pembro; MK-3475) plus platinum doublet chemotherapy (PDC) as front-line therapy for advanced non-small cell lung cancer (NSCLC): KEYNOTE-021 Cohorts A and C.
inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.8034openalex-snapshot
Avelumab (MSB0010718C), an anti-PD-L1 antibody, in advanced NSCLC patients: A phase 1b, open-label expansion trial in patients progressing after platinum-based chemotherapy.
inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.e14010openalex-snapshot
Pharmacokinetics and pharmacodynamics of MEDI4736, a fully human anti-programmed death ligand 1 (PD-L1) monoclonal antibody, in combination with tremelimumab in patients with advanced non-small cell lung cancer (NSCLC).
inferredcites →https://doi.org/10.1200/jco.2015.33.15_suppl.tps8104openalex-snapshot
A phase III study of MEDI4736 (M), an anti-PD-L1 antibody, in monotherapy or in combination with Tremelimumab (T), versus standard of care (SOC) in patients (pts) with advanced non-small cell lung cancer (NSCLC) who have received at least two prior systemic treatment regimens (ARCTIC).
inferredcites →https://doi.org/10.1200/jco.2015.33.18_suppl.lba109openalex-snapshot
Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non-squamous cell (non-SQ) non-small cell lung cancer (NSCLC).
inferredcites →https://doi.org/10.1371/journal.pone.0130142openalex-snapshot
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
inferredcites →https://doi.org/10.18632/oncotarget.2757openalex-snapshot
The TLR7 agonist induces tumor regression both by promoting CD4+T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells
inferredcites →https://doi.org/10.2217/thy.10.84openalex-snapshot
Immunotherapy as a strategy for the treatment of non-small-cell lung cancer
inferredcites →https://doi.org/10.3109/08830185.2012.698338openalex-snapshot
The Use of Agonistic Anti-CD40 Therapy in Treatments for Cancer
inferredcites →https://doi.org/10.4049/jimmunol.0803826openalex-snapshot
Locally Administered TLR7 Agonists Drive Systemic Antitumor Immune Responses That Are Enhanced by Anti-CD40 Immunotherapy
inferredcites →https://doi.org/10.4049/jimmunol.165.11.6123openalex-snapshot
In Vivo Cross-Presentation of a Soluble Protein Antigen: Kinetics, Distribution, and Generation of Effector CTL Recognizing Dominant and Subdominant Epitopes
inferredcites →https://doi.org/10.4161/onci.20493openalex-snapshot
Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation
inferredcites →https://doi.org/10.4161/onci.20730openalex-snapshot
Can the exome and the immunome converge on the design of efficient cancer vaccines?
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4654714openalex-extracted
Four Prognostic Related Genes Were Identified by Bio-Informatics Analysis as Key Genes in Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1002/9781394175482.ch8openalex-snapshot
Nanoparticle‐Based mRNA Vaccines
inferred← citeshttps://doi.org/10.1002/cai2.23openalex-snapshot
Opportunities and challenges of immune checkpoint inhibitors for extensive‐stage small‐cell lung cancer
inferred← citeshttps://doi.org/10.1002/cam4.4377openalex-snapshot
Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cam4.6347openalex-snapshot
Guanylate‐binding proteins signature predicts favorable prognosis, immune‐hot microenvironment, and immunotherapy response in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/chem.202403508openalex-snapshot
Supramolecular Assemblies via Host‐Guest Interactions for Tumor Immunotherapy
inferred← citeshttps://doi.org/10.1002/cnr2.1747openalex-snapshot
Gene expression pattern of adenosine receptors in lung tumors
inferred← citeshttps://doi.org/10.1002/cti2.1076openalex-snapshot
The role and therapeutic implications of T cells in cancer of the lung
inferred← citeshttps://doi.org/10.1002/ctm2.492openalex-snapshot
Pyroptosis, metabolism, and tumor immune microenvironment
inferred← citeshttps://doi.org/10.1002/jcla.24086openalex-snapshot
Dysregulated ferroptosis‐related genes indicate potential clinical benefits for anti–PD‐1/PD‐L1 immunotherapy in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1002/jgm.3731openalex-snapshot
Building endoplasmic reticulum stress‐related LncRNAs signatures of lung adenocarcinoma
inferred← citeshttps://doi.org/10.1002/jmri.27977openalex-snapshot
A Comparative Study of Amide Proton Transfer Weighted Imaging and Intravoxel Incoherent Motion MRI Techniques Versus (18) F‐FDG PET to Distinguish Solitary Pulmonary Lesions and Their Subtypes
inferred← citeshttps://doi.org/10.1002/tox.24284openalex-snapshot
Advancing predictive markers in lung adenocarcinoma: A machine learning‐based immunotherapy prognostic prediction signature
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_216-1openalex-snapshot
Introduction to Cancer Treatment
inferred← citeshttps://doi.org/10.1007/978-3-032-00769-8_216openalex-snapshot
Introduction to Cancer Treatment
inferred← citeshttps://doi.org/10.1007/978-3-319-96244-3_18openalex-snapshot
The Future of Mesothelioma Research: Basic Science Research
inferred← citeshttps://doi.org/10.1007/978-981-99-7141-1_18openalex-snapshot
Insight on the Clinical Trials of Immunotherapy for the Treatment of Lung Cancer
inferred← citeshttps://doi.org/10.1007/978-981-99-7141-1_3openalex-snapshot
Evolution of Lung Cancer Treatment from Classical Chemotherapy to Advanced Immunotherapy
inferred← citeshttps://doi.org/10.1007/s00251-021-01223-8openalex-snapshot
Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy
inferred← citeshttps://doi.org/10.1007/s00262-021-02949-wopenalex-snapshot
CD38 identifies pre-activated CD8+ T cells which can be reinvigorated by anti-PD-1 blockade in human lung cancer
inferred← citeshttps://doi.org/10.1007/s00262-021-03020-4openalex-snapshot
An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors
inferred← citeshttps://doi.org/10.1007/s00428-025-04392-zopenalex-snapshot
Prevalence and clinico-morphological correlates of STK11 mutations in a large cohort of NSCLC lung adenocarcinomas
inferred← citeshttps://doi.org/10.1007/s00432-024-05687-5openalex-snapshot
Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s00432-024-05774-7openalex-snapshot
Comprehensive molecular analyses of cuproptosis-related genes with regard to prognosis, immune landscape, and response to immune checkpoint blockers in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s10528-022-10190-yopenalex-snapshot
Bioinformatics Analysis and Experimental Study of Exonuclease 1 Gene in Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s10571-022-01198-4openalex-snapshot
Prognostic Significance of mRNA Expression RBBP8 or Its Methylation in Gliomas
inferred← citeshttps://doi.org/10.1007/s10753-021-01547-3openalex-snapshot
Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells
inferred← citeshttps://doi.org/10.1007/s11033-022-08180-9openalex-snapshot
Immunotherapeutics in lung cancers: from mechanistic insight to clinical implications and synergistic perspectives
inferred← citeshttps://doi.org/10.1007/s12010-022-04098-xopenalex-snapshot
Construction of a Prognostic Evaluation Model for Stomach Adenocarcinoma on the Basis of Immune-Related lncRNAs
inferred← citeshttps://doi.org/10.1007/s12032-023-02036-3openalex-snapshot
Tumor infiltrating lymphocytes and radiological picture of the tumor
inferred← citeshttps://doi.org/10.1007/s12094-024-03412-9openalex-snapshot
Patterns of immunotherapy utilization for non-small cell lung cancer in Texas pre- and post-regulatory approval
inferred← citeshttps://doi.org/10.1007/s13258-022-01238-9openalex-snapshot
NEDD4L suppresses PD-L1 expression and enhances anti-tumor immune response in A549 cells
inferred← citeshttps://doi.org/10.1007/s13258-022-01306-0openalex-snapshot
MiR-30c facilitates natural killer cell cytotoxicity to lung cancer through targeting GALNT7
inferred← citeshttps://doi.org/10.1007/s13353-023-00786-4openalex-snapshot
Modern therapies of nonsmall cell lung cancer
inferred← citeshttps://doi.org/10.1007/s40259-023-00628-zopenalex-snapshot
Immunotherapy Guided by Immunohistochemistry PD-L1 Testing for Patients with NSCLC: A Microsimulation Model-Based Effectiveness and Cost-Effectiveness Analysis
inferred← citeshttps://doi.org/10.1007/s42114-025-01335-9openalex-snapshot
Intelligent nanoparticles loaded simultaneously with anti-PD-L1 and anti-CTLA-4 for photothermal immunotherapy of lung cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-812034-7.00020-0openalex-snapshot
Combination Therapies in Solid Tumour Oncology
inferred← citeshttps://doi.org/10.1016/b978-0-323-96128-8.00007-9openalex-snapshot
Microflora impacts immune system and its antitumor function
inferred← citeshttps://doi.org/10.1016/b978-0-443-44585-9.00015-9openalex-snapshot
Navigating toxicity in lung cancer immunotherapy: Challenges and advances in nanomedicine drug delivery
inferred← citeshttps://doi.org/10.1016/j.addr.2023.114831openalex-snapshot
Aerosol pulmonary immune engineering
inferred← citeshttps://doi.org/10.1016/j.bbadis.2023.166789openalex-snapshot
Exploring low-dose radiotherapy to overcome radio-immunotherapy resistance
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111429openalex-snapshot
Novel insights for lncRNA MAGI2-AS3 in solid tumors
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113628openalex-snapshot
Aqueous extract of Taxus chinensis var. mairei targeting CD47 enhanced antitumor effects in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116275openalex-snapshot
Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer
inferred← citeshttps://doi.org/10.1016/j.canlet.2026.218743openalex-snapshot
Circular RNA-based therapeutic vaccine elicits potent antigen-specific antitumor immunity and remodels tumor microenvironment in lung cancer
inferred← citeshttps://doi.org/10.1016/j.ccmp.2021.100005openalex-snapshot
Correlation of ARNTL2 with Immune Infiltration and Its Role as a Potential Prognostic Biomarker in Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.ceh.2023.06.001openalex-snapshot
Immune aging and pulmonary diseases
inferred← citeshttps://doi.org/10.1016/j.clgc.2023.06.011openalex-snapshot
Comprehensive Analyses Revealed Eight Immune Related Signatures Correlated With Aberrant Methylations as Prognosis and Diagnosis Biomarkers for Kidney Renal Papillary Cell Carcinoma
inferred← citeshttps://doi.org/10.1016/j.cllc.2025.08.011openalex-snapshot
Immune Checkpoint Inhibitor Without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A Real-World Retrospective Study
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2022.112655openalex-snapshot
In situ self-assembled peptide enables effective cancer immunotherapy by blockage of CD47
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2025.108689openalex-snapshot
Targeting colorectal cancer liver metastasis through repurposing metabolic and immune inhibitors: A theoretical study
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2023.106597openalex-snapshot
A novel basement membrane-related gene signature for prognosis of lung adenocarcinomas
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2021.103417openalex-snapshot
Immunotherapy for non-small cell lung cancer (NSCLC), as a stand-alone and in combination therapy
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2025.06.001openalex-snapshot
Exploring AI tools and multi-omics for precision medicine in lung cancer therapy
inferred← citeshttps://doi.org/10.1016/j.drudis.2023.103701openalex-snapshot
Fragmented antibodies in non-small cell lung cancer: A novel nano-engineered delivery system for detection and treatment of cancer
inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.119320openalex-snapshot
Therapeutic applications of metal complexes in lung cancer treatment
inferred← citeshttps://doi.org/10.1016/j.ejso.2021.02.016openalex-snapshot
The sequence of pulmonary vessels ligation during lobectomy for non-small cell lung cancer: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.gendis.2024.101279openalex-snapshot
MDM2 inhibitors in cancer immunotherapy: Current status and perspective
inferred← citeshttps://doi.org/10.1016/j.genrep.2022.101649openalex-snapshot
Role of A1 adenosine receptor in survival of human lung cancer
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e34784openalex-snapshot
Comprehensive analysis of single-cell RNA and bulk RNA sequencing based on M2 tumor-associated macrophage and angiogenesis-related genes to assess prognosis and therapeutic response in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2025.125395openalex-snapshot
Deciphering a crosstalk between biological cues and multifunctional nanocarriers in lung cancer therapy
inferred← citeshttps://doi.org/10.1016/j.imbio.2023.152391openalex-snapshot
Peripheral changes in T cells predict efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.imbio.2024.152839openalex-snapshot
Selenium nanoparticles enhance the anti-tumor immune responses of anti-4-1BB antibody and alleviate the adverse effects on mice
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.107594openalex-snapshot
The efficacy and safety of combination therapy with immune checkpoint inhibitors in non-small cell lung cancer: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.107886openalex-snapshot
Breast cancer immunotherapy: Current and novel approaches
inferred← citeshttps://doi.org/10.1016/j.intimp.2022.108848openalex-snapshot
Comparative safety of immune checkpoint inhibitors and chemotherapy in advanced non-small cell lung cancer: A systematic review and network meta-analysis
inferred← citeshttps://doi.org/10.1016/j.jconrel.2017.05.023openalex-snapshot
Advances in combination therapy of lung cancer: Rationales, delivery technologies and dosage regimens
inferred← citeshttps://doi.org/10.1016/j.jep.2022.115573openalex-snapshot
Integrating network pharmacology and transcriptomic validation to investigate the efficacy and mechanism of Mufangji decoction preventing lung cancer
inferred← citeshttps://doi.org/10.1016/j.jrras.2025.101407openalex-snapshot
A 3D residual network-based approach for accurate lung nodule segmentation in CT images
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.119505openalex-snapshot
Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis
inferred← citeshttps://doi.org/10.1016/j.lungcan.2021.02.010openalex-snapshot
Survival analysis for non-squamous NSCLC patients harbored STK11 or KEAP1 mutation receiving atezolizumab
inferred← citeshttps://doi.org/10.1016/j.molimm.2022.09.005openalex-snapshot
Histone deacetylase 2 regulates STAT1-dependent upregulation of atypical chemokine receptor 3 to induce M2 macrophage migration and immune escape in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.mtbio.2026.103196openalex-snapshot
A sequentially programmed Fe2O3 hollow multishelled nanoplatform for ferroptosis-amplified lung cancer therapy and macrophage-related innate immune remodeling
inferred← citeshttps://doi.org/10.1016/j.omton.2024.200895openalex-snapshot
FOS+ B cells: Key mediators of immunotherapy resistance in diverse cancer types
inferred← citeshttps://doi.org/10.1016/j.phymed.2023.155219openalex-snapshot
Tannins in Phyllanthus emblica L. improves cisplatin efficacy in lung cancer cells by boosting endoplasmic reticulum stress to trigger immunogenic cell death
inferred← citeshttps://doi.org/10.1016/j.prp.2023.154621openalex-snapshot
Comprehensive analyses of genome-wide methylation and RNA epigenetics identify prognostic biomarkers, regulating the tumor immune microenvironment in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.prp.2026.156486openalex-snapshot
Opioids and cancer biology: Exploring the dark side of pain relief
inferred← citeshttps://doi.org/10.1016/j.rmcr.2020.101258openalex-snapshot
Acute pneumothorax due to immunotherapy administration in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.semcdb.2016.09.008openalex-snapshot
Roles of immune microenvironment heterogeneity in therapy-associated biomarkers in lung cancer
inferred← citeshttps://doi.org/10.1016/j.tranon.2021.101309openalex-snapshot
Chimeric antigen receptor T cells targeting CD147 for non-small cell lung cancer therapy
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.2c00353openalex-snapshot
PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective
inferred← citeshttps://doi.org/10.1038/s41598-021-00272-zopenalex-snapshot
Multi-omics analysis of m6A modification-related patterns based on m6A regulators and tumor microenvironment infiltration in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1038/s41598-023-43699-2openalex-snapshot
Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis
inferred← citeshttps://doi.org/10.1038/s41598-023-46252-3openalex-snapshot
A novel tumor immunotherapy-related signature for risk stratification, prognosis prediction, and immune status in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1039/9781837676439-00380openalex-snapshot
Inhalable Nanoparticles for Lung Immunotherapy
inferred← citeshttps://doi.org/10.1039/d3cs00585bopenalex-snapshot
Design strategies and applications of cyanine dyes in phototherapy
inferred← citeshttps://doi.org/10.1039/d3tb02844eopenalex-snapshot
Manganese-based nanomaterials promote synergistic photo-immunotherapy: green synthesis, underlying mechanisms, and multiple applications
inferred← citeshttps://doi.org/10.1042/bsr20201491openalex-snapshot
Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma
inferred← citeshttps://doi.org/10.1063/5.0276007openalex-snapshot
Lung cancer segmentation using deep learning approach
inferred← citeshttps://doi.org/10.1080/08830185.2024.2333275openalex-snapshot
Boosting immune responses in lung tumor immune microenvironment: A comprehensive review of strategies and adjuvants
inferred← citeshttps://doi.org/10.1080/10799893.2021.2019274openalex-snapshot
XIST/miR-34a-5p/PDL1 axis regulated the development of lung cancer cells and the immune function of CD8+ T cells
inferred← citeshttps://doi.org/10.1080/14737140.2022.2116005openalex-snapshot
The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: an updated systematic review and meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1080/15384047.2023.2285367openalex-snapshot
Serum ferritin level is an effective prognostic factor for lung cancer immunotherapy
inferred← citeshttps://doi.org/10.1080/2162402x.2024.2327692openalex-snapshot
Lymphatic endothelial cell-mediated accumulation of CD177 + Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma
inferred← citeshttps://doi.org/10.1080/21645515.2023.2202127openalex-snapshot
Adjuvant DNA vaccine pNMM promotes enhanced specific immunity and anti-tumor effects
inferred← citeshttps://doi.org/10.1080/21655979.2021.2017577openalex-snapshot
miR-3648 promotes lung adenocarcinoma-genesis by inhibiting SOCS2 (suppressor of cytokine signaling 2)
inferred← citeshttps://doi.org/10.1080/23311908.2025.2496022openalex-snapshot
Could decision aids be helpful during medical consultations? semi-structured interviews with oncologists within the I3LUNG project
inferred← citeshttps://doi.org/10.1088/1361-6528/ad170bopenalex-snapshot
Advances in the variations and biomedical applications of stimuli-responsive nanodrug delivery systems
inferred← citeshttps://doi.org/10.1089/jir.2024.0242openalex-snapshot
Research Hotspots of Interferon Gamma in the Treatment of Lung Cancer: A Bibliometric Analysis Based on CiteSpace
inferred← citeshttps://doi.org/10.1093/cei/uxad137openalex-snapshot
FGL1 in plasma extracellular vesicles is correlated with clinical stage of lung adenocarcinoma and anti-PD-L1 response
inferred← citeshttps://doi.org/10.1097/cji.0000000000000362openalex-snapshot
Encephalitis Induced by Durvalumab During Treatment of Metastatic Small-Cell Lung Cancer: Illustrative Case and Review of the Literature
inferred← citeshttps://doi.org/10.1097/cm9.0000000000002991openalex-snapshot
Recent advances and remaining challenges in lung cancer therapy
inferred← citeshttps://doi.org/10.1097/cmr.0000000000000785openalex-snapshot
A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio.
inferred← citeshttps://doi.org/10.1097/js9.0000000000003029openalex-snapshot
Stemness-associated WNT3A and EDN3 as key regulators of tumor progression and immunotherapy efficacy in LUAD
inferred← citeshttps://doi.org/10.1097/md.0000000000019533openalex-snapshot
Clinical course of non-small cell lung cancer patients with dry pleural dissemination
inferred← citeshttps://doi.org/10.1097/md.0000000000027121openalex-snapshot
Efficacy and safety of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitor versus chemotherapy for advanced lung cancer
inferred← citeshttps://doi.org/10.1097/md.0000000000027841openalex-snapshot
LKB1 expression and the prognosis of lung cancer
inferred← citeshttps://doi.org/10.1097/md.0000000000033472openalex-snapshot
Prognostic value of O6-methylguanine-DNA methyltransferase hypermethylation and expression in head and neck cancer: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1097/md.0000000000038574openalex-snapshot
The predictive value of E2F7 in immunotherapy efficacy for lung adenocarcinoma: An observational study
inferred← citeshttps://doi.org/10.1097/mou.0000000000000733openalex-snapshot
An update on systemic therapy for penile cancer
inferred← citeshttps://doi.org/10.1097/pai.0000000000001085openalex-snapshot
Comparison of 22C3-PD-L1 Expression Between Paired Tumor Paraffin Blocks of Surgical Resection Specimens of Nonsmall Cell Lung Cancer
inferred← citeshttps://doi.org/10.1101/2020.12.21.423874openalex-snapshot
Identification of Potential Antibody Epitopes in MMP-15
inferred← citeshttps://doi.org/10.1101/2022.04.23.489290openalex-snapshot
Identifying Proteasome 26S Subunit, ATPase ( PSMC ) Family Genes as the Prognostic Indicators and Therapeutic Targets in Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1101/2024.12.03.24318450openalex-snapshot
Autoimmune side-effect of immunotherapy in lung cancer treatment revealed from large-scale cohort
inferred← citeshttps://doi.org/10.1111/1759-7714.13939openalex-snapshot
miRNA ‐218‐5p increases cell sensitivity by inhibiting PRKDC activity in radiation‐resistant lung carcinoma cells
inferred← citeshttps://doi.org/10.1111/1759-7714.14614openalex-snapshot
Feasibility and oncological outcomes of video‐assisted thoracic surgery versus thoracotomy for pathologic N2 disease in non–small cell lung cancer: A comprehensive systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1111/crj.13745openalex-snapshot
Efficacy of immune checkpoint inhibitors in advanced non‐small cell lung cancer patients with KRAS mutations: A network meta‐analysis
inferred← citeshttps://doi.org/10.1111/j.1440-1843.2009.01484.xopenalex-snapshot
Road ahead to respiratory health: Experts chart future research directions
inferred← citeshttps://doi.org/10.1111/jcmm.17641openalex-snapshot
Intratumoral immune heterogeneity of prostate cancer characterized by typing and hub genes
inferred← citeshttps://doi.org/10.1111/jcmm.70586openalex-snapshot
Twist1 Regulates the Immune Checkpoint VISTA and Promotes the Proliferation, Migration and Progression of Pancreatic Cancer Cells
inferred← citeshttps://doi.org/10.1111/resp.12809openalex-snapshot
Update in lung cancer: epilogue to a modern review series
inferred← citeshttps://doi.org/10.1111/resp.13016openalex-snapshot
Year in review 2016: Respiratory infections, acute respiratory distress syndrome, pleural diseases, lung cancer and interventional pulmonology
inferred← citeshttps://doi.org/10.1111/resp.13381openalex-snapshot
How do new molecular tools apply to my clinical practice?
inferred← citeshttps://doi.org/10.1139/bcb-2019-0435openalex-snapshot
Amplified LncRNA PVT1 promotes lung cancer proliferation and metastasis by facilitating VEGFC expression
inferred← citeshttps://doi.org/10.1142/s0192415x2250032xopenalex-snapshot
A Clinical Study on the Relationship Among Insomnia, Tongue Diagnosis, and Oral Microbiome
inferred← citeshttps://doi.org/10.1152/physiolgenomics.00042.2025openalex-snapshot
Multidimensional characterization of the tumor microenvironment profiles in lung squamous cell carcinoma
inferred← citeshttps://doi.org/10.1155/2020/9418593openalex-snapshot
Antiangiogenesis Roles of Exosomes with Fei‐Liu‐Ping Ointment Treatment are Involved in the Lung Carcinoma with the Lewis Xenograft Mouse Model
inferred← citeshttps://doi.org/10.1155/2021/8175003openalex-snapshot
A New Definition of Pyroptosis‐Related Gene Markers to Predict the Prognosis of Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1155/2022/1112987openalex-snapshot
Aberrant ROS Served as an Acquired Vulnerability of Cisplatin‐Resistant Lung Cancer
inferred← citeshttps://doi.org/10.1155/2022/2099327openalex-snapshot
Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1155/2022/2195393openalex-snapshot
miR-381 Inhibits Proliferation and Invasion of Non-Small-Cell Cancer Cells by Targeting USP39
inferred← citeshttps://doi.org/10.1155/2022/3306189openalex-snapshot
The Roles of EXO1 and RPA1 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy
inferred← citeshttps://doi.org/10.1155/2022/4312117openalex-snapshot
Prediction of Lung Infection during Palliative Chemotherapy of Lung Cancer Based on Artificial Neural Network
inferred← citeshttps://doi.org/10.1155/2022/4662874openalex-snapshot
Immune Effect of T Lymphocytes Infiltrated by Tumors on Non-Small-Cell Lung Cancer
inferred← citeshttps://doi.org/10.1155/2022/5244820openalex-snapshot
Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1155/2022/5436988openalex-snapshot
EMT-Related Gene Signature Predicts the Prognosis in Uveal Melanoma Patients
inferred← citeshttps://doi.org/10.1155/2022/6567916openalex-snapshot
Prognostic Risk Signature and Comprehensive Analyses of Endoplasmic Reticulum Stress-Related Genes in Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1155/2022/7904982openalex-snapshot
Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1155/2022/8069858openalex-snapshot
A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1155/2022/8348499openalex-snapshot
NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target
inferred← citeshttps://doi.org/10.1155/2022/8809956openalex-snapshot
Application of Cytochrome C-Related Genes in Prognosis and Treatment Prediction of Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1155/2022/9142903openalex-snapshot
Mining Database to Identify Aging-Related Molecular Subtype and Prognostic Signature in Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1155/2023/2333767openalex-snapshot
Alkylresorcinols as a New Type of Gut Microbiota Regulators Influencing Immune Therapy Efficiency in Lung Cancer Treatment
inferred← citeshttps://doi.org/10.1155/2023/9292536openalex-snapshot
High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-21-0203openalex-snapshot
SAGE1: a Potential Target Antigen for Lung Cancer T-Cell Immunotherapy
inferred← citeshttps://doi.org/10.1159/000450570openalex-snapshot
Netzwerke zur interdisziplinären Therapiesteuerung ermöglichen individualisierte Medizin
inferred← citeshttps://doi.org/10.1159/000455147openalex-snapshot
Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations
inferred← citeshttps://doi.org/10.1172/jci148291openalex-snapshot
BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases
inferred← citeshttps://doi.org/10.1177/0300060519850417openalex-snapshot
Associations of lymphocyte percentage and red blood cell distribution width with risk of lung cancer
inferred← citeshttps://doi.org/10.1177/03008916211022834openalex-snapshot
Emergency rigid bronchoscopy and immunotherapy: successful combination in dramatic respiratory debut of pulmonary adenocarcinoma
inferred← citeshttps://doi.org/10.1177/11795549231199915openalex-snapshot
SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas
inferred← citeshttps://doi.org/10.1177/2324709620965010openalex-snapshot
Atezolizumab-Induced Bell’s Palsy in a Patient With Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1186/s12880-024-01380-8openalex-snapshot
CT-based deep learning radiomics biomarker for programmed cell death ligand 1 expression in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1186/s12885-020-07403-1openalex-snapshot
Relationship between the invasion of lymphocytes and cytokines in the tumor microenvironment and the interval after single brachytherapy hypofractionated radiotherapy and conventional fractionation radiotherapy in non-small cell lung Cancer
inferred← citeshttps://doi.org/10.1186/s12885-022-10046-zopenalex-snapshot
Validating ORR and PFS as surrogate endpoints in phase II and III clinical trials for NSCLC patients: difference exists in the strength of surrogacy in various trial settings
inferred← citeshttps://doi.org/10.1186/s12885-024-12727-3openalex-snapshot
The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1186/s12890-022-02184-8openalex-snapshot
Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1186/s12890-023-02443-2openalex-snapshot
Construction of an endoplasmic reticulum stress-related signature in lung adenocarcinoma by comprehensive bioinformatics analysis
inferred← citeshttps://doi.org/10.1186/s12890-023-02681-4openalex-snapshot
Pathogen distribution in pulmonary infection in chinese patients with lung cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s12904-020-0539-xopenalex-snapshot
First referral to an integrated onco-palliative care program: a retrospective analysis of its timing
inferred← citeshttps://doi.org/10.1186/s12935-020-01671-4openalex-snapshot
CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1186/s12951-023-01958-4openalex-snapshot
Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
inferred← citeshttps://doi.org/10.1186/s12976-021-00142-1openalex-snapshot
How mathematical modeling could contribute to the quantification of metastatic tumor burden under therapy: insights in immunotherapeutic treatment of non-small cell lung cancer
inferred← citeshttps://doi.org/10.1186/s13045-020-00978-zopenalex-snapshot
Novel therapies are changing treatment paradigms in metastatic prostate cancer
inferred← citeshttps://doi.org/10.1186/s13045-022-01242-2openalex-snapshot
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
inferred← citeshttps://doi.org/10.1186/s13046-019-1333-6openalex-snapshot
Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B
inferred← citeshttps://doi.org/10.1186/s13578-020-00499-9openalex-snapshot
KLHL18 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by inhibiting PI3K/PD-L1 axis activity
inferred← citeshttps://doi.org/10.1186/s13613-018-0426-2openalex-snapshot
Characteristics and outcome of patients with newly diagnosed advanced or metastatic lung cancer admitted to intensive care units (ICUs)
inferred← citeshttps://doi.org/10.1186/s40364-022-00364-6openalex-snapshot
CAR-NK cells for cancer immunotherapy: from bench to bedside
inferred← citeshttps://doi.org/10.12677/acm.2022.12121690openalex-snapshot
Clinical Progress and Prospect of Traditional Chinese Medicine Combined with Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1293/tox.2022-0040openalex-snapshot
Chemical-induced lung tumor in Tg-rasH2 mice: a novel mouse tumor model to assess immune checkpoint inhibitors combined with a chemotherapy drug
inferred← citeshttps://doi.org/10.1371/journal.pone.0237947openalex-snapshot
The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer
inferred← citeshttps://doi.org/10.1371/journal.pone.0242982openalex-snapshot
Anlotinib for refractory advanced non-small-cell lung cancer: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.14348/molcells.2021.0044openalex-snapshot
Clinical Perspectives to Overcome Acquired Resistance to Anti–Programmed Death-1 and Anti–Programmed Death Ligand-1 Therapy in Non-Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.14814/phy2.70157openalex-snapshot
Trim13‐induced ubiquitination of RPS27A inhibits the progression of lung cancer by depending on the inactivation of NF ‐ κB signaling pathway
inferred← citeshttps://doi.org/10.15761/cmr.1000158openalex-snapshot
Integration of active specific immunotherapy and cell therapy into the protocols of biomedical management of interstitial pneumonia with autoimmune features – A case study
inferred← citeshttps://doi.org/10.1615/critreveukaryotgeneexpr.2023048936openalex-snapshot
A Pan-Cancer Analysis to Provide Insight into the Immunological Role and Prognostic Value of HTRA3
inferred← citeshttps://doi.org/10.1615/critrevtherdrugcarriersyst.2024053289openalex-snapshot
Unlocking the Molecular Targets in Non-Small-Cell Lung Cancer and a Nanomedicine-Based Remedy
inferred← citeshttps://doi.org/10.1631/jzus.b2200292openalex-snapshot
USH2A mutation and specific driver mutation subtypes are associated with clinical efficacy of immune checkpoint inhibitors in lung cancer
inferred← citeshttps://doi.org/10.17148/iarjset.2021.8581openalex-snapshot
An Overview of Non-Small Cell Lung Cancer and its Efficient clinical Management Technique
inferred← citeshttps://doi.org/10.17650/1726-9784-2019-19-2-47-54openalex-snapshot
IMMUNOLOGICAL PARAMETERS OF BONE MARROW IN NON-SMALL CELL LUNG CANCER
inferred← citeshttps://doi.org/10.18632/aging.104075openalex-snapshot
Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma
inferred← citeshttps://doi.org/10.18632/aging.204244openalex-snapshot
Prognostic alternative splicing events related splicing factors define the tumor microenvironment and pharmacogenomic landscape in lung adenocarcinoma
inferred← citeshttps://doi.org/10.18632/aging.204693openalex-snapshot
Comprehensive analyses reveal the prognosis and biological function roles of chromatin regulators in lung adenocarcinoma
inferred← citeshttps://doi.org/10.18632/aging.205381openalex-snapshot
G6PD is a prognostic biomarker correlated with immune infiltrates in lung adenocarcinoma and pulmonary arterial hypertension
inferred← citeshttps://doi.org/10.18632/aging.206053openalex-snapshot
Pan-cancer analysis of immune checkpoint receptors and ligands in various cells in the tumor immune microenvironment
inferred← citeshttps://doi.org/10.18632/oncotarget.8205openalex-snapshot
Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies
inferred← citeshttps://doi.org/10.21007/etd.cghs.2019.0493openalex-snapshot
Design, Development and Evaluation of Dual Drug Nanomedicine for Non-Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.21037/apm-20-449openalex-snapshot
Comparison between the first-line and second-line immunotherapy drugs in the progression-free survival and overall survival in advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.21037/atm-21-1852openalex-snapshot
The prognostic landscape of tumor-infiltrating immune cells in lung squamous cell carcinoma
inferred← citeshttps://doi.org/10.21037/atm-22-1430openalex-snapshot
SLC2A1 plays a significant prognostic role in lung adenocarcinoma and is associated with tumor immunity based on bioinformatics analysis
inferred← citeshttps://doi.org/10.21037/jtd-22-1000openalex-snapshot
Histone acetylation modification regulator-mediated tumor microenvironment infiltration characteristics and prognostic model of lung adenocarcinoma patients
inferred← citeshttps://doi.org/10.21037/tcr-20-2275openalex-snapshot
Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma
inferred← citeshttps://doi.org/10.21037/tlcr-2020-lcmc-08openalex-snapshot
Multidisciplinary team care in lung cancer
inferred← citeshttps://doi.org/10.21037/tlcr-21-144openalex-snapshot
Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer
inferred← citeshttps://doi.org/10.21037/tlcr-21-79openalex-snapshot
Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study
inferred← citeshttps://doi.org/10.21037/tlcr-21-958openalex-snapshot
PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm
inferred← citeshttps://doi.org/10.21037/tlcr-22-464openalex-snapshot
Safety and efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients with preexisting antinuclear antibodies: a retrospective cohort study
showing the first 200 of 334 · page through all 334
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.